- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Primary Progressive Multiple Sclerosis in United Kingdom
Total 2277 results
-
University Hospitals of North Midlands NHS TrustActive, not recruiting
-
Anokion SAActive, not recruitingRelapsing Remitting Multiple Sclerosis | Multiple Sclerosis (MS)United States
-
Opexa Therapeutics, Inc.CompletedRelapsing-Remitting Multiple SclerosisUnited States
-
University at BuffaloWithdrawn
-
University at BuffaloCharles University, Czech Republic; General University Hospital, PragueCompletedMultiple Sclerosis, Relapsing-remittingUnited States
-
BayerCompletedMultiple SclerosisGermany, Austria, United Kingdom, Israel, Belgium, Finland
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedRelapsing-Remitting Multiple SclerosisUnited States, Albania, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Estonia, Georgia, Greece, Latvia, Macedonia, The Former Yugoslav Republic of, Mexico, Moldova, Republic of, Montenegro, Poland, Romania, Russian... and more
-
GlaxoSmithKlineCompletedMultiple SclerosisItaly, Germany, Spain, United Kingdom, Australia, Netherlands, New Zealand, Russian Federation, France, Canada, Austria, Poland, Finland, Norway
-
BiogenAbbVieTerminatedRelapsing-Remitting Multiple Sclerosis (RRMS)Italy, United States, Canada, Germany, Puerto Rico
-
Providence Health & ServicesGenentech, Inc.CompletedRelapsing Remitting Multiple SclerosisUnited States
-
National Institute of Neurological Disorders and...RecruitingMultiple Sclerosis | Progressive Multifocal LeukoencephalopathyUnited States
-
Beth Israel Deaconess Medical CenterBiogen; National Multiple Sclerosis SocietyCompletedMultiple Sclerosis | Progressive Multifocal LeukoencephalopathyUnited States
-
Providence Health & ServicesCompletedRelapsing Remitting Multiple SclerosisUnited States
-
University of VirginiaCompletedRelapsing Remitting Multiple SclerosisUnited States
-
University of Wisconsin, MadisonNational Multiple Sclerosis SocietyCompletedRelapsing Remitting Multiple SclerosisUnited States
-
Johns Hopkins UniversityWithdrawnRelapsing Remitting Multiple SclerosisUnited States
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States, Croatia, Bulgaria, Czech Republic, France, Mexico, Poland, Spain, Germany, Belarus, Estonia, Latvia, Romania, Ukraine, Israel, New Zealand, Slovakia, Greece, India, Serbia, Ireland, Costa Rica, Canada, Belgium, Macedonia,... and more
-
University of Southern CaliforniaNovartis PharmaceuticalsRecruitingRelapsing Remitting Multiple SclerosisUnited States
-
Washington University School of MedicineCompletedRelapsing Remitting Multiple SclerosisUnited States
-
Jeffrey GelfandActive, not recruitingFecal Microbiota Transplantation (FMT) of FMP30 in Relapsing-Remitting Multiple Sclerosis (MS-BIOME)Relapsing Remitting Multiple SclerosisUnited States
-
Regina Elena Cancer InstituteIcahn School of Medicine at Mount Sinai; University of Roma La SapienzaUnknownMultiple Sclerosis | RelapseUnited States, Italy
-
MorphoSys AGCompletedMultiple SclerosisGermany, Poland, United Kingdom
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisSweden, United States, Brazil, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Ukraine, Denmark, Finland, Romania, Canada, France, Hungary, Israel, Switzerland, Serbia, India, Mexico, Poland, Georgia, Ireland, Argentin... and more
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
NovartisCompletedEfficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis (FREEDOMS)Relapsing-remitting Multiple SclerosisCanada, Australia, Israel, Belgium, Czech Republic, Finland, France, Germany, Greece, Lithuania, Netherlands, Poland, Russian Federation, Slovakia, South Africa, Sweden, Switzerland, Turkey, United Kingdom
-
NovartisCompletedMultiple SclerosisGreece, Russian Federation, Switzerland, Germany, Israel, Ireland, Belgium, Finland, United Kingdom, Netherlands, Canada, Romania, Hungary, Poland, Czech Republic, Australia, Estonia, France, Slovakia, South Africa, Sweden, Turkey
-
Johns Hopkins UniversityUniversity of California, San Francisco; National Multiple Sclerosis SocietyCompletedMultiple Sclerosis, Relapsing-remittingUnited States
-
SanofiCompletedMultiple SclerosisUnited Kingdom
-
TG Therapeutics, Inc.Completed
-
IMS HEALTH GmbH & Co. OHGEMD SeronoCompletedRelapsing-remitting Multiple SclerosisUnited States, Canada
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisBelgium, Germany, Italy, Norway, France, Mexico, Australia, Spain, Portugal, Greece, Netherlands, United Kingdom, Czechia, Slovakia, Finland, Canada, Argentina, Brazil
-
ActelionCompletedMultiple SclerosisPoland, Ukraine, United Kingdom, United States, Germany, Spain, Bulgaria, Romania, Serbia, Canada, Finland, Sweden, Russian Federation, Hungary, Czechia, Netherlands, Israel, Switzerland, Austria, France
-
Rocky Mountain MS Research Group, LLCBiogenTerminatedRelapsing Remitting Multiple SclerosisUnited States
-
Genzyme, a Sanofi CompanyCompletedRelapsing Remitting Multiple SclerosisUnited States, Argentina, Australia, Belgium, Brazil, Canada, Czechia, Denmark, Germany, Israel, Italy, Mexico, Netherlands, Poland, Russian Federation, Spain, Sweden, Ukraine, United Kingdom
-
Wave Life Sciences Ltd.TerminatedALS | FTDNetherlands, United Kingdom
-
Eli Lilly and CompanyCompletedRelapsing-Remitting Multiple SclerosisHungary, United States, France, Ukraine, Poland, Germany, Israel, Russian Federation, Czechia, Serbia, Romania, Slovakia, Bulgaria
-
BiogenCompletedMultiple SclerosisUnited States, Italy, Hungary, United Kingdom, Spain, France, Australia, Germany, Canada, Switzerland, Argentina, Czech Republic, Croatia
-
Novartis PharmaceuticalsRecruitingRelapsing-Remitting Multiple SclerosisCanada, United States
-
University of NottinghamRecruitingFeasibility of Neuromodulation With Connectivity-Guided iTBS for Cognitive Impairment in MS (TMS4MS)Multiple Sclerosis | Cognitive ImpairmentUnited Kingdom
-
Hoffmann-La RocheActive, not recruitingMultiple SclerosisUnited States, Italy, Poland
-
Bristol-Myers SquibbTerminated
-
Washington Neuropsychology Research GroupGenzyme, a Sanofi CompanyUnknownRelapsing Remitting Multiple SclerosisUnited States
-
Queen Mary University of LondonCompleted
-
GlaxoSmithKlineCompletedMultiple SclerosisUnited Kingdom
-
Novartis PharmaceuticalsTerminatedRelapsing-remitting Multiple Sclerosis (RRMS)United States, Canada, Mexico, Brazil, Puerto Rico, Argentina, Chile
-
Synthon BVCompletedMultiple SclerosisUnited States, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Estonia, Georgia, Germany, Italy, Mexico, Moldova, Republic of, Poland, Romania, Russian Federation, Serbia, South Africa, Ukraine, United Kingdom
-
NovartisCompletedMultiple SclerosisUnited States, Turkey, Romania, United Kingdom, Poland, Austria, Canada, Australia
-
Banner Life Sciences LLCCompletedRelapsing Remitting Multiple SclerosisUnited States
-
Amanda IrishCompletedMultiple Sclerosis, Relapsing-remittingUnited States
-
University of StirlingWithdrawnMultiple Sclerosis | Chronic Cerebrospinal Venous InsufficiencyUnited Kingdom